ALFUZOSIN AUROVITAS
10MG TBL PRO 100
| SÚKL code | 0229197 |
|---|---|
| Name of the product | ALFUZOSIN AUROVITAS |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ALFUZOSIN AUROVITAS |
| Supplement | 10MG TBL PRO 100 |
| Strenght | 10MG |
| Pharmaceutical form | Prolonged-release tablet |
| Package | 100 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | ALFUZOSIN HYDROCHLORIDE (ALFUZOSINI HYDROCHLORIDUM) |
| ATC group | G04CA01 |
| ATC group name | ALFUZOSIN |
Marketing authorisation information
| Registration Number | 77/ 214/14-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 04. 2020 |
| MA Holder | Aurovitas Pharma Polska Sp. z o.o., Warszawa |
| MA Holder country | POLSKO |
| Actual MA holder | Aurovitas, spol. s r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz